In contrast, other CHIP-related genes, such as ASXL1 and TET2, were less frequently mutated in younger than in older NPM1-mut AML patients (1% vs. 4% and 17% vs. 27%, respectively) [44]. The gene discussed is NPM1; the disease is acute myeloid leukemia.